QuidelOrtho Corporation - Common Stock — 현금 흐름 (NASDAQ:QDEL)

Financials

영업활동으로 인한 현금 885.3 M280.2 M83 M105.2 M 6.6 M 투자 활동으로 인한 현금 -1.64 B-187.6 M-149.9 M-192.7 M -170.5 M 재무활동으로 인한 현금 252 M-265.8 M48.8 M155.8 M 175.8 M 잉여 현금 흐름 885.3 M280.2 M83 M-83 M -159.4 M

QuidelOrtho Corporation - Common Stock

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.

QDEL

Financials

QuidelOrtho Corporation - Common Stock

뉴스

QuidelOrtho: A Growing, Stable Business With A Significant Mispricing (NASDAQ:QDEL)

McIntyre Partnerships Q1 2026 Partners Letter

QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y

QuidelOrtho Corporation (QDEL) Q1 2026 Earnings Call Transcript

QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates

Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline

QuidelOrtho Looks Mispriced If 2026's FCF Turnaround Materializes (NASDAQ:QDEL)

Stocks Settle Higher on Tech Earnings and Ceasefire Optimism

Stocks Edge Higher as Chipmakers Rebound

Stocks Pressured by Weakness in Chipmakers

Why Diagnostics Names CareDx And QuidelOrtho Just Diverged